The traditional healthcare system offered a reactive model: when you fall ill, you visit a…
TechPharus
Latest Posts
Blueprint for Tomorrow: Abu Dhabi’s Genomic Vision for Healthcare
Abu Dhabi is leading a genomic revolution that promises to reshape healthcare by deeply understanding…
The UAE’s Expanding Life Sciences Ecosystem: A New Global Powerhouse
The UAE’s healthcare and life-science sector is experiencing rapid growth, powered by a robust ecosystem…
Building the Future of Pharma: Abu Dhabi’s Strategic Leap
Abu Dhabi’s Pharmaceutical Sector: Rising to Global Prominence Over the past decade, Abu Dhabi—one of…
How the UAE is Shaping the Future of Longevity and Healthspan
The United Arab Emirates is swiftly positioning itself as a global leader in the Longevity…
Interview with Dr. Priyanka Mathur, MediPocket World
We recently spoke to Dr. Priyanka Mathur, a visionary healthcare leader with international healthcare experience…
HealthTech News
- New structures come into view in brain wiring mapson November 21, 2026 at 8:00 pm
Researchers at Harvard Medical School and the University of California San Diego have sped up a powerful imaging technique enough to map, for the first time, large volumes of brain tissue in nanoscale detail. The approach reveals fine structures that brain wiring maps, known as connectomes, can miss.
- Stress and anxiety are wearing workers down: How to spot your triggers and copeon November 21, 2026 at 7:00 pm
Workplace stress and anxiety. Who hasn’t experienced it?
- Alcohol may weaken cancer immunotherapy, early research suggestson November 21, 2026 at 4:00 pm
Cancer immunotherapy has transformed treatment for several advanced cancers, yet the difference between these treatments working and not could depend on simple routine habits. A recent study published in Science Signaling explores one such overlooked factor: regular alcohol consumption.
- Despite soaring demand for GLP-1s, many eligible patients are unable to access these drugs for weight losson November 21, 2026 at 2:00 pm
In just a few short years, glucagon-like peptide-1 (GLP-1) receptor agonists have surged in popularity across the United States, transforming from specialized treatments for type 2 diabetes into revolutionary therapeutics for weight management, cardiovascular health and other emerging uses. But not all populations are benefiting from this expansion. As GLP-1 use has increased, disparities in access to these drugs have widened significantly, according to a new study led by researchers at Boston University School of Public Health (BUSPH).
- Giving patients a greater voice in their diabetes careon November 21, 2026 at 1:00 pm
In two related papers published in JAMA Network Open and the Journal of General Internal Medicine, Kasia Lipska, M.D., associate professor of medicine (endocrinology) at Yale School of Medicine (YSM) and her colleagues tested a new approach to incorporating patients’ priorities into their diabetes care.




